Log in to save to my catalogue

Pharmacotherapy of Hyperlipidemia in Pediatric Heart Transplant Recipients: Current Practice and Fut...

Pharmacotherapy of Hyperlipidemia in Pediatric Heart Transplant Recipients: Current Practice and Fut...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68904362

Pharmacotherapy of Hyperlipidemia in Pediatric Heart Transplant Recipients: Current Practice and Future Directions

About this item

Full title

Pharmacotherapy of Hyperlipidemia in Pediatric Heart Transplant Recipients: Current Practice and Future Directions

Publisher

Switzerland: Springer

Journal title

Paediatric drugs, 2005, Vol.7 (6), p.391-396

Language

English

Formats

Publication information

Publisher

Switzerland: Springer

More information

Scope and Contents

Contents

Lipoprotein abnormalities are fairly common after pediatric heart transplantation. Graft coronary artery disease (GCAD) limits long-term survival and has been linked to elevated serum triglyceride levels and decreased high-density lipoprotein levels. Histologically, GCAD represents intimal hyperplasia of the coronary vessel and is best imaged by in...

Alternative Titles

Full title

Pharmacotherapy of Hyperlipidemia in Pediatric Heart Transplant Recipients: Current Practice and Future Directions

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68904362

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68904362

Other Identifiers

ISSN

1174-5878

DOI

10.2165/00148581-200507060-00007

How to access this item